Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sutro Biopharma Inc. (STRO)

9.94   -0.11 (-1.09%) 10-01 14:09
Open: 10.1 Pre. Close: 10.05
High: 10.27 Low: 9.7336
Volume: 74,761 Market Cap: 357M
Sutro Biopharma Inc. engages in the drug discovery, development, and manufacturing of pharmaceutical products. The company is headquartered in South San Francisco, California and currently employs 169 full-time employees. The firm is focused on using its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics for cancer and autoimmune disorders. The company focuses to design therapeutics using potent modalities, including cytokine-based immuno-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidate includes STRO-001 and STRO-002. STRO-001 is an ADC directed against the cancer target CD74, for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002 is an ADC directed against folate receptor-alpha (FolRa), for patients with ovarian and endometrial cancers. STRO-001 and STRO-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its XpressCF Platform.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.36 - 10.419 10.419 - 10.483
Low: 9.591 - 9.654 9.654 - 9.722
Close: 9.928 - 10.04 10.04 - 10.162

Technical analysis

as of: 2020-10-01 1:40:07 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 14.07     One year: 16.25
Support: Support1: 9.04    Support2: 7.52
Resistance: Resistance1: 12.05    Resistance2: 13.91
Pivot: 10.65
Moving Average: MA(5): 10.17     MA(20): 11.11
MA(100): 9.41     MA(250): 9.99
MACD: MACD(12,26): 0.03     Signal(9): 0.25
Stochastic oscillator: %K(14,3): 9.55     %D(3): 11.56
RSI: RSI(14): 44.11
52-week: High: 13.91  Low: 6.00  Change(%): 17.3
Average Vol(K): 3-Month: 33774  10-Days: 38408

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
STRO has closed above bottom band by 13.5%. Bollinger Bands are 13.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 28 Sep 2020
Sutro Biopharma Inc (NASDAQ:STRO) Short Interest Up 78.1% in September - MarketBeat

Mon, 21 Sep 2020
Sutro Biopharma Named Best New Drug Developer at the 7th Annual World ADC - BioSpace

Wed, 16 Sep 2020
Sutro Biopharma Inc (NASDAQ:STRO) Applauds The Encouraging STRO-002 Interim Phase 1 Clinical Data - BP Journal

Tue, 15 Sep 2020
Sutro Biopharma Inc (NASDAQ:STRO) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Thu, 10 Sep 2020
Should You Buy Sutro Biopharma Inc (STRO) in Biotechnology Industry? - InvestorsObserver

Wed, 09 Sep 2020
Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting - PRNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 36
Shares Float (M) 21
% Held by Insiders 21.16
% Held by Institutions 69.52
Shares Short (K) 752
Shares Short P. Month (K) 767

Stock Financials

EPS -0.710
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 5.760
Profit Margin -43.34
Operating Margin -162.33
Return on Assets (ttm) -17.5
Return on Equity (ttm) -10.7
Qtrly Rev. Growth -10.0
Gross Profit (p.s.) -0.638
Sales Per Share 1.120
EBITDA (p.s.) -1.690
Qtrly Earnings Growth
Operating Cash Flow (M) -61
Levered Free Cash Flow (M) -24

Stock Valuations

PE Ratio -13.93
PEG Ratio
Price to Book value 1.72
Price to Sales 8.83
Price to Cash Flow -5.86

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.